Please assess the completion status of the following clinical trial:

Trial Title: My Dose Coach Mobile App to Support Insulin Titration and Maintenance

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Intervention Group~* Patient receiving care at a UPMC Diabetes Outpatient and/or Inpatient settings~* Adult male and female patients 18 to 75 years old~* HbA1c \> 7.5%~* Recommended to start self titration of basal insulin~* Access to and able to use an iOS (Apple phone operating system) or Android enabled device and have reliable internet access~* Willing and able to use the MDC app~* Able to comprehend basic diabetes survival skills, signs and symptoms of hypoglycemia and treatment of BG~Usual Care Group~* Adult male and female patients 18 to 75 years old~* HbA1c \> 7.5%~* Started on basal insulin in a UPMC Diabetes Outpatient facility within the past three years of study start~* Has blood glucose data available in electronic medical records (EMR) (At least two HbA1c measurements corresponding to baseline and a subsequent time point after insulin titration)~Exclusion Criteria:~* Pregnant or breastfeeding~* Patients unwilling to use MDC app

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- My Dose Coach (Insulin Dosing Support App) (Type: EXPERIMENTAL): Phase 1 Titration: Patients receive insulin therapy education from diabetes educator (DE). Plus, DE trains patients to use My Dose Coach (MDC) for titration guidance according to an algorithm prepared by endocrinology provider (EP). Patients are asked to return for a 3-month (mo) follow-up clinic visit. Patients who successfully reach glycemic target are invited to Phase 2. Other patients are invited to continue titrating for another 3 months.~Phase 2 Maintenance: At 3-mo clinic visit, an EP or DE trains patients the MDC Maintenance Module to support proper insulin dosing. Patients are asked to return for follow-up clinic visits at mo 6.~Patients are surveyed (0, 3, 6 mo) to assess changes in behavioral and psychosocial factors that influence diabetes self-management and MDC acceptability.
- Usual Care Group (Type: ACTIVE_COMPARATOR): A retrospective comparative group will be selected from eligible patients who previously were treated at the University of Pittsburgh Medical Center (UPMC) Diabetes Outpatient Clinics following standard insulin therapy education. Patients in the usual care group will be identified using data available in the electronic medical record system. Propensity score matching will be used to pair intervention and usual care participants during phase 1 of the study (baseline to 3 months).

Based on this trial design, predict the completion outcome and termination type (if applicable).